Señales en vivo de MEDP | Maximiza tus Ganancias con Getagraph.com

VENDER 313 min ago

@ $391.17

Emitido: 1 may 2024 @ 13:20

Retorno: 1.71%

Señal anterior: abr 30 - 11:52

Señal anterior: Comprar

Retorno: -0.83 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Stats
Volumen de hoy	280 957
Volumen promedio	284 201
Capitalización de mercado	12.33B
EPS	$0 ( 2024-04-22 )
Próxima fecha de ganancias	( $2.50 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	40.64
ATR14	$16.42 (4.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Troendle August J.	Sell	15 102	Common Stock
2024-04-30	Troendle August J.	Sell	1 828	Common Stock
2024-03-31	Kraft Robert O.	Buy	72	Common Stock
2024-03-31	Kraft Robert O.	Sell	72	Restricted Stock Unit
2024-03-31	Mccarthy Cornelius P. Iii	Buy	63	Common Stock

INSIDER POWER
-94.52
Last 100 transactions
Buy: 68 908 \| Sell: 2 488 859

Volumen Correlación

Largo: 0.79 (moderate)

Corto: -0.47 (neutral)

Signal:(41) Neutral

Medpace Holdings Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medpace Holdings Inc Correlación - Moneda/Commodity

0.75
( moderate )

0.77
( moderate )

-0.66
( moderate negative )

0.59
( weak )

-0.25
( neutral )

Medpace Holdings Inc Finanzas

Annual	2023
Ingresos:	$1.89B
Beneficio Bruto:	$524.51M (27.81 %)
EPS:	$9.20

FY	2023
Ingresos:	$1.89B
Beneficio Bruto:	$524.51M (27.81 %)
EPS:	$9.20

FY	2022
Ingresos:	$1.46B
Beneficio Bruto:	$432.44M (29.62 %)
EPS:	$7.57

FY	2021
Ingresos:	$1.14B
Beneficio Bruto:	$328.16M (28.73 %)
EPS:	$5.08

Financial Reports:

No articles found.

Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.